Silicone breast implant policy: FDA designee is needed to find "solution" -- Rep. Shays.

This article was originally published in The Gray Sheet

07 Aug 1995
News

Executive Summary

SILICONE BREAST IMPLANTS: FDA DESIGNEE NEEDED TO FIND "SOLUTION" to the current regulatory status of the devices, Rep. Christopher Shays (R-Conn.) told FDA Commissioner David Kessler at an Aug. 1 hearing on silicone breast implants. The joint hearing was held by the House Government Reform/Human Resources Subcommittee, chaired by Shays, and the National Economic Growth Subcommittee.

Already Registered? Sign in to continue reading.

New to Medtech Insight? Start a free trial today!

Table
View full table

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

MT004513

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

MT004513

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Silicone breast implant policy: FDA designee is needed to find "solution" -- Rep. Shays.

News

Executive Summary

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert